Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 7/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15528690 | 0.81 | KDM4E (0.42) | KDM4EKMT2AGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL9390898 | 0.79 | KDM4E (0.37) | KDM4E | |
| SCHEMBL5069095 | 0.77 | GSK3A (0.50) | KDM4EKMT2ANFKB1NFKB2RELA | |
| SCHEMBL13182184 | 0.74 | KDM4E (0.44) | KDM4EKMT2AMEN1GAAALDH1A1 | |
| SCHEMBL19959701 | 0.73 | NFKB1 (0.40) | KDM4EKMT2AMEN1NFKB1NFKB2 | |
| SCHEMBL10908440 | 0.73 | ALDH1A1 (0.42) | KDM4EKMT2AMEN1GAAALDH1A1 | |
| SCHEMBL4132084 | 0.72 | KDM4E (0.36) | KDM4E | |
| SCHEMBL1162244 | 0.72 | KDM4E (0.38) | KDM4EGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL7590942 | 0.72 | KDM4E (0.57) | KDM4EKMT2AMEN1GAAALDH1A1 | |
| SCHEMBL9066916 | 0.72 | JUN (0.49) | NFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4337673-B1 | PSD-95 INHIBITORS AND USES THEREOF | UNIV COPENHAGEN (DK) | 2025-07-09 | — | — | EP | disclosed |
| US-20250215052-A1 | INHIBITORS OF PICK1 AND USES THEREOF | UNIVERSITY OF COPENHAGEN (DK) | 2025-07-03 | — | — | US | disclosed |
| US-20240245793-A1 | PSD-95 INHIBITORS AND USES THEREOF | UNIVERSITY OF COPENHAGEN (DK) | 2024-07-25 | — | — | US | disclosed |
| EP-4337673-A1 | PSD-95 INHIBITORS AND USES THEREOF | University of Copenhagen (DK) | 2024-03-20 | — | — | EP | disclosed |
| CN-117295755-A | PSD-95 inhibitor and application thereof | 哥本哈根大学 | 2023-12-26 | — | — | CN | disclosed |
| CN-116940594-A | Compositions, kits and methods useful for analyzing samples containing antibodies | 沃特世科技公司 | 2023-10-24 | — | — | CN | disclosed |
| WO-2022238530-A1 | PSD-95 INHIBITORS AND USES THEREOF | UNIVERSITY OF COPENHAGEN (DK) | 2022-11-17 | — | — | WO | disclosed |
| US-20210347821-A1 | INHIBITORS OF PICK1 AND USES THEREOF | UNIVERSITY OF COPENHAGEN (DK) | 2021-11-11 | — | — | US | disclosed |
| US-9902754-B2 | Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction | UNIVERSITY OF COPENHAGEN (DK) | 2018-02-27 | — | — | US | disclosed |
| US-20160176924-A1 | MODIFIED PEPTIDES AS POTENT INHIBITORS OF THE PSD-95/NMDA RECEPTOR INTERACTION | UNIVERSITY OF COPENHAGEN (DK) | 2016-06-23 | — | — | US | disclosed |
| EP-2320927-A2 | MODIFIED PEPTIDES AS POTENT INHIBITORS OF THE PSD-95/NMDA RECEPTOR INTERACTION | University of Copenhagen (DK) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010004003-A2 | MODIFIED PEPTIDES AS POTENT INHIBITORS OF THE PSD-95/NMDA RECEPTOR INTERACTION | UNIVERSITY OF COPENHAGEN (DK) | 2010-01-14 | — | — | WO | disclosed |
| US-20090285780-A1 | PEG LINKER COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES THEREOF | LEE CHYI | 2009-11-19 | — | — | US | disclosed |
| EP-2089052-A1 | PEG LINKER COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES THEREOF | Peg Biosciences (US) | 2009-08-19 | — | — | EP | disclosed |
| WO-2007140282-A1 | PEG LINKER COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES THEREOF | PEG BIOSCIENCES (US) | 2007-12-06 | — | — | WO | disclosed |
| EP-0399184-B1 | Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay | ABBOTT LAB (US) | 1995-09-13 | — | — | EP | disclosed |
| US-5354693-A | Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassy | ABBOTT LABORATORIES (US) | 1994-10-11 | — | — | US | disclosed |
| US-5248791-A | Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay | ABBOTT LABORATORIES (US) | 1993-09-28 | — | — | US | disclosed |
| US-5101015-A | Nitrogen-functional-group-containing immunogen | ABBOTT LABORATORIES (US) | 1992-03-31 | — | — | US | disclosed |
| EP-0399184-A2 | Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay | ABBOTT LABORATORIES (US) | 1990-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090285780-A1 | PEG LINKER COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES THEREOF | MSN, MPEG1, GNE | KDM4E 2397/4885KMT2A 3934/4885MEN1 1267/4885 |
| US-20160176924-A1 | MODIFIED PEPTIDES AS POTENT INHIBITORS OF THE PSD-95/NMDA RECEPTOR INTERACTION | PSD, GRIN1, GRIN3B | KDM4E 382/4885KMT2A 365/4885MEN1 1391/4885 |
| US-20210347821-A1 | INHIBITORS OF PICK1 AND USES THEREOF | DRG1, OPRL1, GAB1 | KDM4E 3624/4885KMT2A 2727/4885MEN1 4268/4885 |
| US-20250215052-A1 | INHIBITORS OF PICK1 AND USES THEREOF | DRG1, PSD, DAB2IP | KDM4E 3532/4885KMT2A 2718/4885MEN1 4428/4885 |
| US-20240245793-A1 | PSD-95 INHIBITORS AND USES THEREOF | PSD, PDLIM5, HDLBP | KDM4E 3238/4885KMT2A 3279/4885MEN1 4590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.